Abstract

Delta (Δ) 5 desaturase is a key enzyme for the biosynthesis of health-beneficial long chain polyunsaturated fatty acids such as arachidonic acid (ARA, C20:4n-6), eicosapentaenoic acid (C20:5n-3) and docosahexaenoic acid (C22:6n-3) via the “desaturation and elongation” pathways. A full length Δ5 desaturase gene from Euglena gracilis (EgΔ5D) was isolated by cloning the products of polymerase chain reaction with degenerate oligonucleotides as primers, followed by 5′ and 3′ rapid amplification of cDNA ends. The whole coding region of EgΔ5D was 1,350 nucleotides in length and encoded a polypeptide of 449 amino acids. BlastP search showed that EgΔ5D has about 39 % identity with a Δ5 desaturase of Phaeodactylum tricornutum. In a genetically modified dihomo-gamma-linoleic acid (DGLA, C20:3n-6) producing Yarrowia lipolytica strain, EgΔ5D had strong Δ5 desaturase activity with DGLA to ARA conversion of more than 24 %. Functional dissection of its HPGG and HDASH motifs demonstrated that both motifs were important, but not necessary in the exact form as encoded for the enzyme activity of EgΔ5D. A double mutant EgΔ5D-34G158G with altered sequences within both HPGG and HDASH motifs was generated and exhibited Δ5 desaturase activity similar to the wild type EgΔ5D. Codon optimization of the N-terminal region of EgΔ5D-34G158G and substitution of the arginine with serine at residue 347 improved substrate conversion to 27.6 %.Electronic supplementary materialThe online version of this article (doi:10.1007/s11745-012-3690-1) contains supplementary material, which is available to authorized users.

Highlights

  • There is increasing interest in the recognized health benefits of long chain polyunsaturated fatty acids (LC-PUFA) such as arachidonic acid (ARA, C20:4n-6), eicosapentaenoic acid (EPA, C20:5n-3) and docosahexaenoic acid (DHA, C22:6n-3) for both humans and animals [1,2,3]

  • We report the isolation of a D5 desaturase gene from Euglena gracilis (EgD5D)

  • We studied the significance of the serine residue at position 158 (S158) within the HDASH motif of EgD5D

Read more

Summary

Introduction

There is increasing interest in the recognized health benefits of long chain polyunsaturated fatty acids (LC-PUFA) such as arachidonic acid (ARA, C20:4n-6), eicosapentaenoic acid (EPA, C20:5n-3) and docosahexaenoic acid (DHA, C22:6n-3) for both humans and animals [1,2,3]. Since mammals lack delta (D) 12- and D15-desaturases, ARA, EPA and DHA cannot be synthesized de novo and must be obtained either in the diet or synthesized through ‘‘desaturation and elongation’’ pathways (Fig. 1) from essential fatty acids linoleic acid (LNA, 18:2n-6) and/or alpha (a)-linolenic acid (ALA 18:3n-3). These LC-PUFA are important fatty acids for human growth and development. EPA and DHA are the precursors of E- and D-series resolvins, respectively. Increased intake of EPA-rich supplement has beneficial effects on coronary heart disease, high blood pressure, inflammatory disorders and mental illness [9, 10]

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.